Cargando…
Lysine Methyltransferase Inhibitors Impair H4K20me2 and 53BP1 Foci in Response to DNA Damage in Sarcomas, a Synthetic Lethality Strategy
BACKGROUND: Chromatin is dynamically remodeled to adapt to all DNA-related processes, including DNA damage responses (DDR). This adaptation requires DNA and histone epigenetic modifications, which are mediated by several types of enzymes; among them are lysine methyltransferases (KMTs). METHODS: KMT...
Autores principales: | Campillo-Marcos, Ignacio, Monte-Serrano, Eva, Navarro-Carrasco, Elena, García-González, Raúl, Lazo, Pedro A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446283/ https://www.ncbi.nlm.nih.gov/pubmed/34540832 http://dx.doi.org/10.3389/fcell.2021.715126 |
Ejemplares similares
-
VRK1 Depletion Facilitates the Synthetic Lethality of Temozolomide and Olaparib in Glioblastoma Cells
por: Navarro-Carrasco, Elena, et al.
Publicado: (2021) -
Targets of histone H3 lysine 9 methyltransferases
por: Levinsky, Aidan J., et al.
Publicado: (2022) -
Structural Paradigms in the Recognition of the Nucleosome Core Particle by Histone Lysine Methyltransferases
por: Janna, Ashley, et al.
Publicado: (2020) -
Mechanisms of synthetic lethality between BRCA1/2 and 53BP1 deficiencies and DNA polymerase theta targeting
por: Ronson, George E., et al.
Publicado: (2023) -
Effects of shielding on the induction of 53BP1 foci and micronuclei after Fe ion exposures
por: Hu, Wentao, et al.
Publicado: (2014)